Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L DeJager

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Digestive Diseases|March 1, 1972
Hepatitis after Konyne administrationM M Oken, L Hootkin, R L DeJager
Cancer Research|July 15, 1988
Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigenU C Traub, R L DeJager, F J Primus, et al.
Cancer Research|February 1, 1990
Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodiesM J Losman, R L DeJager, M Monestier, et al.
Dermatologica|January 1, 1989
The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasmsR A Schwartz, D J Goldberg, F Mahmood, et al.
European Journal of Nuclear Medicine|March 1, 1994
Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodiesM A Plaizier, J C Roos, G J Teule, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsE Boven, H J Haisma, H Bril, et al.
In Vivo (Athens, Greece)|November 1, 1993
Distribution and kinetics of 131I-labeled human IgM monoclonal antibody 16.88 in patients with advanced colorectal cancerJ C Roos, M A Plaizier, A van Lingen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Digestive Diseases|March 1, 1972
Hepatitis after Konyne administrationM M Oken, L Hootkin, R L DeJager
Cancer Research|July 15, 1988
Antiidiotype antibodies in cancer patients receiving monoclonal antibody to carcinoembryonic antigenU C Traub, R L DeJager, F J Primus, et al.
Cancer Research|February 1, 1990
Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodiesM J Losman, R L DeJager, M Monestier, et al.
Dermatologica|January 1, 1989
The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasmsR A Schwartz, D J Goldberg, F Mahmood, et al.
European Journal of Nuclear Medicine|March 1, 1994
Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodiesM A Plaizier, J C Roos, G J Teule, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsE Boven, H J Haisma, H Bril, et al.
In Vivo (Athens, Greece)|November 1, 1993
Distribution and kinetics of 131I-labeled human IgM monoclonal antibody 16.88 in patients with advanced colorectal cancerJ C Roos, M A Plaizier, A van Lingen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.
Pageof 1